Generic name: ELETRIPTAN HYDROBROMIDE 20mg
Dosage form: tablet, film coated
Medically reviewed on February 14, 2018.
The maximum recommended single dose is 40 mg.
In controlled clinical trials, single doses of 20 mg and 40 mg were effective for the acute treatment of migraine in adults. A greater proportion of patients had a response following a 40 mg dose than following a 20 mg dose [see Clinical Studies (14)].
If the migraine has not resolved by 2 hours after taking RELPAX, or returns after transient improvement, a second dose may be administered at least 2 hours after the first dose. The maximum daily dose should not exceed 80 mg.
The safety of treating an average of more than 3 migraine attacks in a 30-day period has not been established.
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
More about Relpax (eletriptan)
- Relpax Side Effects
- During Pregnancy or Breastfeeding
- Drug Images
- Drug Interactions
- Support Group
- Pricing & Coupons
- En Español
- 130 Reviews
- Generic Availability
- Drug class: antimigraine agents
- FDA Alerts (1)